Reaktionsgleichung
[N:1]1([CH2:6][CH2:7][N:8]2[C:16]3[C:11](=[CH:12][CH:13]=[C:14]([NH2:17])[CH:15]=3)[CH:10]=[N:9]2)[CH2:5][CH2:4][CH2:3][CH2:2]1.[C:18]1([C:31]2[CH:36]=[CH:35][CH:34]=[CH:33][CH:32]=2)[CH:23]=[CH:22][C:21]([C:24](=[O:30])[CH2:25][CH2:26][C:27](O)=[O:28])=[CH:20][CH:19]=1>>[C:18]1([C:31]2[CH:32]=[CH:33][CH:34]=[CH:35][CH:36]=2)[CH:23]=[CH:22][C:21]([C:24](=[O:30])[CH2:25][CH2:26][C:27]([NH:17][C:14]2[CH:15]=[C:16]3[C:11]([CH:10]=[N:9][N:8]3[CH2:7][CH2:6][N:1]3[CH2:5][CH2:4][CH2:3][CH2:2]3)=[CH:12][CH:13]=2)=[O:28])=[CH:20][CH:19]=1Komponenten
3
Versuchsvorschrift
According to the procedure for Example 49, 1-(2-pyrrolidin-1-yl-ethyl)-1H-indazol-6-ylamine and 4-biphenyl-4-yl-4-oxo-butyric acid were processed to provide the title compound. 1H NMR (500 MHz, DMSO-d6) δ ppm 1.80 (m, 2 H), 1.97 (m, 2 H), 2.83 (t, J=6.10 Hz, 2 H), 3.02 (m, 2 H), 3.41 (t, J=6.26 Hz, 2 H), 3.50 (m, 2 H), 3.69 (m, 2 H), 4.66 (t, J=6.26 Hz, 2 H), 7.11 (m, 1 H), 7.45 (m, 1 H), 7.52 (m, 2 H), 7.72 (m, 1 H), 7.77 (m, 2 H), 7.86 (m, 2 H), 8.10 (m, 3 H), 8.29 (s, 1 H), 9.56 (br s, N H); MS (DCI/NH3) m/z 467 (M+H)+.
Quellen und Nachweise
- ORD-Eintrag
- ord-b24fa47016af4ab1b82440c8af12450c
- Quelldatensatz
- uspto-grants-2006_07
- Patentnummer
- US07071182B2
Verknüpfte Notizen
Wird geladen…